AI Co-Scientist formRNA Therapeutics
The first equivariant foundation model for mRNA design (NeurIPS 2025), powering an AI co-scientist platform for the $50B+ mRNA therapeutics market.
Two Ways We Solve It
Helixir AI Platform
Self-serve mRNA design for researchers and biotech teams. Immediate access, immediate value.
- Self-serve, start free
- Pay-as-you-go pricing
- Scales with your research
Pharma Partnerships
Custom mRNA design programs for pharma and biotech. Higher-value engagements with milestone-based upside.
- Per-program engagement
- Milestone + royalty structure
- Dedicated support team
Why DeepBio Scientific
World Model Architecture
A provenance-grounded world model that reasons across biological systems, not just pattern-matching on molecules.
Higher Success Rates
Calibrated probability models predict and improve clinical success, addressing the 90% failure rate problem.
30-50% Time Savings
Cut years off development timelines with AI-driven automation across every pipeline stage.
AgentFabric™
Specialist agents debate and iterate, with a judge agent forcing explicit tradeoffs and decisions.
Trial Optimization
AI-generated protocols, patient matching, and eligibility criteria that maximize recruitment and success.
Full Audit Trail
Every prediction traced to source data. No hallucinations, just grounded, explainable reasoning.
Join Us in Building a Disease-Free World
Partner with us to accelerate your therapeutic program from concept to clinic.